|Validated and novel patient reported outcome measures assessed during the Hypo COMPaSS trial|
|Validated PRO measures||Novel PRO measures undergoing validation|
|• The Gold Score ||• The Hypoglycaemia Awareness Questionnaire (HypoA-Q)*|
|• The Edinburgh Hypoglycaemia Survey ||• The Hypoglycaemia Burden Questionnaire (HypoB-Q)* – part A only|
|• Clarke Hypoglycaemia Awareness Questionnaire (minimally modified version)|
|• The Hypoglycaemia Fear Survey II (HFS II) ||• The Hypoglycaemia Cues Questionnaires (HypoC-Q)*|
|• The Hyperglycaemia Avoidance Scale ||• The Blood Glucose Monitoring Questionnaire (BGM-Q)*|
|• The Diabetes Treatment Satisfaction Questionnaire – status version (DTSQ(s)) ||• The Quality of Life Questionnaire Diabetes (QoL-Q Diabetes)^|
|• Insulin Treatment Satisfaction Questionnaire  – abridged version including two subscales only||• The Attitudes to Awareness of Hypos Questionnaire#|
|• EuroQoL EQ-5D |
|• Perceived Control of Diabetes scales (type 1) |
* designed by Prof Jane Speight and Dr Shalleen Barendse (Â© AHP Research, 2010).
^ designed by Prof Jane Speight, Dr Alison Woodcock and Matthew Reaney (Â© AHP Research, 2007).
# designed by Dr Nicole DeSoyza, Helen Rogers and Prof Stephanie Amiel (King’s College London).
Little et al.
Little et al. BMC Endocrine Disorders 2012 12:33 doi:10.1186/1472-6823-12-33